FI893519A0 - Menetelmä Lys-plasminogeenin valmistamiseksi - Google Patents

Menetelmä Lys-plasminogeenin valmistamiseksi

Info

Publication number
FI893519A0
FI893519A0 FI893519A FI893519A FI893519A0 FI 893519 A0 FI893519 A0 FI 893519A0 FI 893519 A FI893519 A FI 893519A FI 893519 A FI893519 A FI 893519A FI 893519 A0 FI893519 A0 FI 893519A0
Authority
FI
Finland
Prior art keywords
plasminogen
lys
mol
protein
hours
Prior art date
Application number
FI893519A
Other languages
English (en)
Swedish (sv)
Other versions
FI93518C (fi
FI93518B (fi
FI893519A (fi
Inventor
Yendra Linnau
Ernst Hetzl
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of FI893519A0 publication Critical patent/FI893519A0/fi
Publication of FI893519A publication Critical patent/FI893519A/fi
Application granted granted Critical
Publication of FI93518B publication Critical patent/FI93518B/fi
Publication of FI93518C publication Critical patent/FI93518C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
FI893519A 1988-07-28 1989-07-21 Menetelmä Lys-plasminogeenin valmistamiseksi FI93518C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT191988 1988-07-28
AT0191988A AT390801B (de) 1988-07-28 1988-07-28 Verfahren zur herstellung von lys-plasminogen

Publications (4)

Publication Number Publication Date
FI893519A0 true FI893519A0 (fi) 1989-07-21
FI893519A FI893519A (fi) 1990-01-29
FI93518B FI93518B (fi) 1995-01-13
FI93518C FI93518C (fi) 1995-04-25

Family

ID=3523862

Family Applications (1)

Application Number Title Priority Date Filing Date
FI893519A FI93518C (fi) 1988-07-28 1989-07-21 Menetelmä Lys-plasminogeenin valmistamiseksi

Country Status (10)

Country Link
US (2) US5371007A (fi)
EP (1) EP0353218B1 (fi)
JP (1) JP2521354B2 (fi)
AT (2) AT390801B (fi)
CA (1) CA1334079C (fi)
DE (1) DE58901530D1 (fi)
DK (1) DK371689A (fi)
ES (1) ES2043113T3 (fi)
FI (1) FI93518C (fi)
NO (1) NO175260C (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT390801B (de) * 1988-07-28 1990-07-10 Immuno Ag Verfahren zur herstellung von lys-plasminogen
US4989922A (en) * 1988-11-23 1991-02-05 Lucas Industries Public Limited Company Method of anti-lock brake control for motorcycle vehicle
AT402367B (de) * 1990-10-11 1997-04-25 Immuno Ag Pharmazeutische zubereitung auf basis von lys-plasminogen
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
WO1994013329A1 (de) * 1992-12-16 1994-06-23 Immuno Aktiengesellschaft Verfahren zur herstellung eines virussicheren biologischen präparates
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
US5520912A (en) * 1993-07-02 1996-05-28 Immuno Aktiengesellschaft Prevention and treatment of ischemic events and reperfusion injury resulting therefrom using lys-plasminogen
JPH0739375A (ja) * 1993-07-29 1995-02-10 Green Cross Corp:The プラスミノーゲンの精製方法
DE4411143C2 (de) * 1994-03-30 1996-08-01 Immuno Ag Thrombosemittel
US6068838A (en) * 1996-04-29 2000-05-30 Baxter Aktiengesellschaft Purified multimerase
US6207066B1 (en) 1996-07-23 2001-03-27 Nuvue Technologies, L.L.C. Method for purification of a blood component
US6355243B1 (en) 1999-11-13 2002-03-12 Bayer Corporation Method of thrombolysis by local delivery of active plasmin
US6964764B2 (en) 1999-11-13 2005-11-15 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US7544500B2 (en) * 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
US6969515B2 (en) * 1999-11-13 2005-11-29 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US6855263B2 (en) 2002-07-23 2005-02-15 Nuvue Technologies, Inc. Rapid process for purification and concentration of plasmin
CN1303413C (zh) * 2003-06-17 2007-03-07 余伟明 蛋白质、病毒快速富集方法
US8617863B2 (en) * 2008-06-04 2013-12-31 Grifols Therapeutics Inc. Composition, method, and kit for preparing plasmin
PT2403865E (pt) 2009-03-03 2015-11-18 Grifols Therapeutics Inc Métodos de preparação de plasminogénio

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT390801B (de) * 1988-07-28 1990-07-10 Immuno Ag Verfahren zur herstellung von lys-plasminogen

Also Published As

Publication number Publication date
EP0353218A3 (en) 1990-05-16
ES2043113T3 (es) 1993-12-16
JP2521354B2 (ja) 1996-08-07
DK371689D0 (da) 1989-07-27
FI93518C (fi) 1995-04-25
JPH0297386A (ja) 1990-04-09
FI93518B (fi) 1995-01-13
FI893519A (fi) 1990-01-29
US5556766A (en) 1996-09-17
NO175260B (no) 1994-06-13
AT390801B (de) 1990-07-10
NO893071L (no) 1990-01-29
CA1334079C (en) 1995-01-24
ATE76578T1 (de) 1992-06-15
EP0353218B1 (de) 1992-05-27
US5371007A (en) 1994-12-06
NO893071D0 (no) 1989-07-27
NO175260C (no) 1994-09-21
DE58901530D1 (de) 1992-07-02
EP0353218A2 (de) 1990-01-31
DK371689A (da) 1990-01-29
ATA191988A (de) 1989-12-15

Similar Documents

Publication Publication Date Title
FI893519A0 (fi) Menetelmä Lys-plasminogeenin valmistamiseksi
CA1267620A (en) Cell lines and their use for the production of proteins
Goldberg et al. [50] Proteases in Escherichia coli
Rasmussen et al. Utilization of a depsipeptide substrate for trapping acyl—enzyme intermediates of penicillin-sensitive D-alanine carboxypeptidases
EP0102216A2 (en) Biosynthesis of unnatural cephalosporins
Mäkinen Inhibition by bacitracin of some hydrolytic enzymes
US4908314A (en) Protein C activator
GR3017731T3 (en) Improved enzymatic oxidation of ceph C to glutaryl-7-amino-cephalosporanic acid.
AU4871993A (en) Dictyostelium dipeptidylaminopeptidase
Kivirikko et al. Asymmetry in the hydroxylation of (Pro-Pro-Gly) 5 by protocollagen proline hydroxylase
HU185454B (en) Process for seperating endoprotinase-lys-c
Parrado et al. Kerase immobilization by covalent attachment to porous glass
JP3685814B2 (ja) アミノペプチダーゼおよびその生産方法
Fujiwara et al. Affinity chromatography of neutral and alkaline proteases from Bacillus subtilis and of thermolysin
EP0316907A3 (en) Enzyme inhibitor and method of producing the same
JPS6443192A (en) Dna having genetic information on sarcosine oxidase and use thereof
AU6272286A (en) Genetically engineered microorganisms for production of l-amino acids
HUT52018A (en) Process for production of biohumus with culture of manure-worm
ES8604973A1 (es) Un procedimiento para la preparacion de penicilina v.
ES8604974A1 (es) Un procedimiento para la fabricacion de penicilina g.

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: IMMUNO AKTIENGESELLSCHAFT